Filings (90d)
Other insiders active in the same sector
No other insider has filed at Sessa Capital (Master), L.P.'s companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Eric M. Dube - $41.35M in TVTX purchases and sales in the last 12 months
- Jesse J. Geiger - $41.11M in MEDP purchases and sales in the last 12 months
- Mark Hancock - $40.97M in PACS purchases and sales in the last 12 months
- EcoR1 Capital, LLC - $40.00M in AKTS purchases and sales in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $40.00M in BCAX purchases and sales in the last 12 months
- Sanj K. Patel - $39.43M in KNSA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
What is Sessa Capital (Master), L.P.?
Sessa Capital (Master), L.P. is an investment firm, tracked as Director of SAB Biotherapeutics, Inc. (SABS). InsiderAlpha holds 2 primary Form 4 filings for it, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Sessa Capital (Master), L.P. last file a Form 4?
The most recent primary Form 4 on record is dated 29 September 2025, one of 2 filings going back to 2025.
